Key result
AI and digital tools advance CV prevention, diagnosis, and treatment in high-burden Asian populations.
Why the study?
Digital innovation and AI are rapidly moving into cardiovascular practice, warranting a comprehensive review across the care continuum with a particular focus on Asian populations.
Design
Review
Answers are grounded in this paper and cite their sources.
This review summarizes the current state and translational pathway of AI and digital health tools in cardiovascular medicine, emphasizing their potential to achieve equitable and scalable precision cardiology.
Advances in digital innovation and data science are rapidly transforming cardiovascular medicine, with artificial intelligence, machine learning, and digital health tools now moving from experimental applications into clinical practice. This review provides a comprehensive overview of developments across the cardiovascular care continuum, with a particular focus on Asian populations where the burden of disease is high and health care systems face unique challenges. We highlight the role of large-scale cohort studies, risk prediction algorithms, multimodal artificial intelligence models, and digital innovations such as wearable devices and assistive clinical tools in prevention, diagnosis, treatment, and follow-up. Furthermore, we discuss barriers to implementation, including data quality, infrastructure, and regulatory frameworks. By integrating perspectives from laboratory science to bedside practice, this review outlines both the current state of research and the translational pathway required to achieve precision cardiology that is equitable, scalable, and sustainable.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2026) studied this question. AI and digital tools are rapidly advancing cardiovascular care, enabling improved prevention, diagnosis, and treatment, especially in high-burden Asian populations.
Synapse has enriched 10 related papers. Consider them for comparative context: